Home » All » Stock Forecast » Relmada Therapeutics Inc. Common Stock Forecast

Relmada Therapeutics Inc. Common Stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▼ -3.12%Market Cap $748.90M · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$7.23 ▲ +1.24%	Yesterday	$7.10 ▼ -0.52%	Tomorrow's Relmada Therapeutics Inc. Common Stock (RLMD) setup is anchored to $7.14 and targets $7.23 (+1.24%). The near-term read is upside; watch $7.35 / $6.93 because daily realized volatility is about 6.38%.
Tomorrow's Relmada Therapeutics Inc. Common Stock (RLMD) setup is anchored to $7.14 and targets $7.23 (+1.24%). The near-term read is upside; watch $7.35 / $6.93 because daily realized volatility is about 6.38%.
Week	$7.41 ▲ +3.85%	Last Week	$7.02 ▼ -1.62%	The 7-day Relmada Therapeutics Inc. Common Stock model moves from $7.02 to $7.41 (+3.85%). It gives upside momentum context for this stock, so breaks around $7.35 / $6.93 matter more than a single tick.
The 7-day Relmada Therapeutics Inc. Common Stock model moves from $7.02 to $7.41 (+3.85%). It gives upside momentum context for this stock, so breaks around $7.35 / $6.93 matter more than a single tick.
Month	$7.73 ▲ +8.20%	Last Month	$6.89 ▼ -3.44%	The 1-month Relmada Therapeutics Inc. Common Stock target is $7.73 (+8.20%), compared with the live reference near $7.14. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Relmada Therapeutics Inc. Common Stock target is $7.73 (+8.20%), compared with the live reference near $7.14. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$8.19 ▲ +14.72%	Last Year	$6.70 ▼ -6.18%	The 1-year Relmada Therapeutics Inc. Common Stock scenario points to $8.19 (+14.72%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Relmada Therapeutics Inc. Common Stock scenario points to $8.19 (+14.72%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$9.28 ▲ +30.00%	5 Years Ago	$6.24 ▼ -12.60%	The 5-year Relmada Therapeutics Inc. Common Stock view is $9.28 (+30.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Relmada Therapeutics Inc. Common Stock view is $9.28 (+30.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$7.23▲ +1.24%

Yesterday$7.10▼ -0.52%

Tomorrow's Relmada Therapeutics Inc. Common Stock (RLMD) setup is anchored to $7.14 and targets $7.23 (+1.24%). The near-term read is upside; watch $7.35 / $6.93 because daily realized volatility is about 6.38%.

Week$7.41▲ +3.85%

Last Week$7.02▼ -1.62%

The 7-day Relmada Therapeutics Inc. Common Stock model moves from $7.02 to $7.41 (+3.85%). It gives upside momentum context for this stock, so breaks around $7.35 / $6.93 matter more than a single tick.

Month$7.73▲ +8.20%

Last Month$6.89▼ -3.44%

The 1-month Relmada Therapeutics Inc. Common Stock target is $7.73 (+8.20%), compared with the live reference near $7.14. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$8.19▲ +14.72%

Last Year$6.70▼ -6.18%

The 1-year Relmada Therapeutics Inc. Common Stock scenario points to $8.19 (+14.72%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$9.28▲ +30.00%

5 Years Ago$6.24▼ -12.60%

The 5-year Relmada Therapeutics Inc. Common Stock view is $9.28 (+30.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Neutral

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$7.14	Mid
Daily Change	-3.12%	Below
Volatility Cap	20.0%	Mid
Confidence	64%	Above
Data Source	nasdaq-screener	Mid

Historical Data

Current$7.14

Daily Change-3.12%

Market Cap$748.90M

Sourcenasdaq-screener

Current	$7.14	Daily Change	-3.12%
Market Cap	$748.90M	Source	nasdaq-screener

Support & Resistance Levels

$6.93Support 1

$7.14Current

$7.35Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$7.14Live reference price

Used as the anchor for generated forecast calculations.

Next Month$7.73Model projection+8.20%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

64%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

64%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in RLMD today

Bullish Scenario

$7.50

+5.00% from current

Target Price$7.50

ScenarioUpside momentum

Probability56%

Base Scenario

$7.73

+8.20%

Target Price$7.73

ScenarioCapped drift

Probability64%

Bearish Scenario

$6.78

-5.00% from current

Target Price$6.78

ScenarioVolatility drawdown

Probability36%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 67/100

24H drift+1.24%

7D drift+3.85%

30D drift+8.20%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 65/100

1M outlook+8.20%

1Y outlook+14.72%

5Y outlook+30.00%

Frequently Asked Questions

Q What is the Relmada Therapeutics Inc. Common Stock (RLMD) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Relmada Therapeutics Inc. Common Stock is projected near $7.23 versus the current reference around $7.14. That implies a modeled move of +1.24% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for RLMD?

The weekly Relmada Therapeutics Inc. Common Stock model points to $7.41, which maps to an expected drift of +3.85% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Relmada Therapeutics Inc. Common Stock 1-month and 1-year targets?

The Relmada Therapeutics Inc. Common Stock 1-month target is $7.73 (+8.20%), while the 1-year target is $8.19 (+14.72%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Relmada Therapeutics Inc. Common Stock 5-year scenario differ from short-term rows?

The Relmada Therapeutics Inc. Common Stock long-horizon scenario sits near $9.28 with a modeled change of +30.00%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are RLMD support and resistance zones right now?

For Relmada Therapeutics Inc. Common Stock, nearest resistance is around $6.93, while nearest support is around $7.35. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Relmada Therapeutics Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.